Saturday, 30 May 2015

Eisai drug extends survival in patients with rare cancers

A drug made by Japan`s Eisai Co that was originally derived from sea sponges helped extend lives of patients with soft-tissue cancers known as sarcomas by two months, a significant advance for these rare cancers with few treatment options, Belgian researchers said on Saturday.

from Zee News :Zee News - Health http://bit.ly/1cpzCJK via Health News Daily

No comments:

Post a Comment